Concepedia

Publication | Closed Access

Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes

DOI

30

Citations

22

References

2021

Year

Caroline Holm Nørgaard, Liis Starkopf, Thomas Alexander Gerds, Peter Vestergaard, Anders Nissen Bonde, Emil Loldrup Fosbøl, Lars Køber, Nathan D. Wong, Christian Torp‐Pedersen, Christina J-Y Lee
European Heart Journal - Cardiovascular Pharmacotherapy

Abstract

In this nationwide study of patients with type 2 diabetes, initiating GLP-1RA vs. SGLT-2i was not found to be associated with significant differences in cardiovascular risk.

References

YearCitations

Page 1